Free Trial

Nutrien (NTR) Financials

Nutrien logo
$52.22 +0.10 (+0.20%)
Closing price 03:59 PM Eastern
Extended Trading
$52.55 +0.33 (+0.63%)
As of 06:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Nutrien

Annual Income Statements for Nutrien

This table shows Nutrien's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
327 7,160 1,232 459 6,358 7,687 2,641 1,797
Consolidated Net Income / (Loss)
327 3,573 1,232 459 3,179 7,687 1,282 700
Net Income / (Loss) Continuing Operations
154 3,587 1,232 459 3,179 7,687 1,359 1,097
Total Pre-Tax Income
-29 3,494 1,308 382 4,168 10,246 1,952 1,136
Total Operating Income
209 4,032 1,862 902 4,781 10,809 2,745 1,856
Total Gross Profit
694 5,392 5,502 5,239 9,409 15,424 8,474 7,530
Total Revenue
4,547 18,772 20,084 20,908 27,712 37,884 29,056 25,972
Operating Revenue
4,547 18,772 20,084 20,908 27,712 37,884 29,056 25,972
Total Cost of Revenue
3,853 13,380 14,582 15,669 18,303 22,460 20,582 18,442
Operating Cost of Revenue
3,853 13,380 14,582 15,669 18,303 22,460 20,582 18,442
Total Operating Expenses
485 1,360 3,400 4,337 4,628 4,615 5,652 5,277
Selling, General & Admin Expense
214 2,760 3,013 3,311 3,817 3,979 4,023 4,079
Other Operating Expenses / (Income)
271 409 507 202 778 1,416 855 668
Impairment Charge
0.00 -1,809 -120 824 33 -780 774 530
Total Other Income / (Expense), net
-238 -538 -554 -520 -613 -563 -793 -720
Other Income / (Expense), net
-238 -538 -554 -520 -613 -563 -793 -720
Income Tax Expense
-183 -93 316 -77 989 2,559 670 436
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - 0.00 -26 - -24 -26
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
- - - - -3,153 - -1,258 -674
Basic Earnings per Share
$0.39 $5.72 $1.70 $0.81 $5.53 - $2.53 $1.36
Weighted Average Basic Shares Outstanding
840.08M 624.90M 582.27M 569.66M 569.66M - 496.38M 494.20M
Diluted Earnings per Share
$0.39 $5.72 $1.70 $0.81 $5.52 - $2.53 $1.36
Weighted Average Diluted Shares Outstanding
840.32M 624.90M 583.10M 569.69M 571.29M - 496.99M 494.37M

Quarterly Income Statements for Nutrien

No quarterly income statements for Nutrien are available.


Annual Cash Flow Statements for Nutrien

This table details how cash moves in and out of Nutrien's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
84 3,600 -1,643 243 -2,184 9,968 1,786 2,117
Net Cash From Operating Activities
-1,225 2,052 3,665 3,323 3,886 10,000 2,861 2,806
Net Cash From Continuing Operating Activities
1,081 5,474 3,665 3,323 3,814 10,000 2,861 2,806
Net Income / (Loss) Continuing Operations
327 3,573 992 459 3,179 7,687 1,282 700
Consolidated Net Income / (Loss)
-327 3,573 992 459 3,179 7,687 1,282 700
Depreciation Expense
- 1,592 1,799 1,989 1,951 2,012 2,169 2,339
Non-Cash Adjustments To Reconcile Net Income
-898 1,925 224 893 373 -154 -532 -311
Changes in Operating Assets and Liabilities, net
- -1,616 650 -18 -1,689 455 -58 78
Net Cash From Investing Activities
-652 3,887 -2,798 -1,204 -1,807 0.00 31 112
Net Cash From Continuing Investing Activities
-652 1,867 -2,798 -1,744 -2,964 0.00 31 112
Purchase of Investments
0.00 - -198 - - - 31 112
Net Cash From Financing Activities
-489 -3,705 -2,479 -1,339 -3,003 -32 -1,106 -801
Net Cash From Continuing Financing Activities
-489 -3,705 -2,479 -1,339 -3,003 -32 -1,106 -801
Repayment of Debt
-159 -960 -794 -1,690 -1,195 -561 -648 -659
Issuance of Debt
-1.00 0.00 1,481 1,541 86 529 -458 -142
Cash Interest Paid
- 507 505 498 491 482 729 740

Quarterly Cash Flow Statements for Nutrien

No quarterly cash flow statements for Nutrien are available.


Annual Balance Sheets for Nutrien

This table presents Nutrien's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
16,998 45,502 46,799 47,192 49,954 54,586 52,749 51,840
Total Current Assets
3,323 11,662 10,665 11,470 13,846 16,342 14,170 13,792
Cash & Equivalents
116 2,314 671 1,454 499 901 941 853
Accounts Receivable
489 3,342 3,542 3,626 5,366 6,194 5,398 5,390
Inventories, net
2,646 4,917 4,975 4,930 6,328 7,632 6,336 6,148
Prepaid Expenses
72 1,089 1,477 1,460 1,653 1,615 1,495 1,401
Plant, Property, & Equipment, net
0.00 18,796 20,335 19,660 0.00 0.00 0.00 0.00
Total Noncurrent Assets
13,675 15,044 15,799 16,062 36,108 16,477 15,382 14,746
Goodwill
97 11,431 11,986 12,198 12,220 12,368 12,114 12,043
Intangible Assets
69 2,210 2,428 2,388 2,340 2,297 2,217 1,819
Other Noncurrent Operating Assets
13,509 1,403 564 914 20,845 1,812 1,051 884
Total Liabilities & Shareholders' Equity
16,998 45,502 46,799 47,192 49,954 54,586 52,749 51,840
Total Liabilities
8,695 21,077 23,930 24,789 26,255 28,723 27,548 27,398
Total Current Liabilities
1,602 8,335 9,129 8,480 12,443 14,280 12,121 12,045
Short-Term Debt
730 1,624 1,478 173 2,105 2,684 2,327 2,571
Accrued Expenses
836 - - - 10,052 11,291 9,467 9,118
Other Current Liabilities
- 8.00 214 249 286 305 327 356
Total Noncurrent Liabilities
7,093 12,742 14,801 16,309 13,812 14,443 15,427 15,353
Long-Term Debt
3,711 7,755 8,553 10,047 7,521 8,275 9,113 9,045
Capital Lease Obligations
- 12 859 891 - 899 999 999
Asset Retirement Reserve & Litigation Obligation
651 1,673 1,650 1,597 1,566 1,403 1,489 1,543
Noncurrent Deferred & Payable Income Tax Liabilities
2,205 2,907 3,145 3,149 3,165 3,547 3,574 3,539
Noncurrent Employee Benefit Liabilities
440 395 433 454 419 319 252 227
Total Equity & Noncontrolling Interests
8,303 24,425 22,869 22,403 23,699 25,863 25,201 24,442
Total Preferred & Common Equity
8,303 24,425 22,869 22,403 23,699 25,818 25,156 24,407
Total Common Equity
8,303 24,425 22,869 22,365 23,652 25,818 25,156 24,407
Common Stock
1,806 16,971 16,019 15,878 15,457 14,281 13,921 13,816
Retained Earnings
6,242 7,745 7,101 6,606 8,192 11,928 11,531 11,106
Accumulated Other Comprehensive Income / (Loss)
25 -291 -251 -119 -146 -391 -296 -515
Noncontrolling Interest
- - - - - 45 45 35

Quarterly Balance Sheets for Nutrien

No quarterly balance sheets for Nutrien are available.


Annual Metrics and Ratios for Nutrien

This table displays calculated financial ratios and metrics derived from Nutrien's official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - -
Revenue Growth
0.00% 312.84% 6.99% 4.10% 32.54% 36.71% -23.30% -10.61%
EBITDA Growth
0.00% 17,637.93% -38.91% -23.69% 158.08% 100.33% -66.38% -15.68%
EBIT Growth
0.00% 12,148.28% -62.56% -70.80% 991.10% 145.83% -80.95% -41.80%
NOPAT Growth
0.00% 2,729.34% -65.88% -23.25% 236.45% 122.39% -77.77% -36.56%
Net Income Growth
0.00% 992.66% -65.52% -62.74% 592.59% 141.81% -83.32% -45.40%
EPS Growth
0.00% 1,366.67% -70.28% -52.35% 581.48% 0.00% 0.00% -46.25%
Operating Cash Flow Growth
0.00% 267.51% 78.61% -9.33% 16.94% 157.33% -71.39% -1.92%
Free Cash Flow Firm Growth
0.00% 0.00% 97.03% 555.42% 63.08% 733.33% -86.68% -48.01%
Invested Capital Growth
0.00% 149.46% 5.97% -2.38% 1.98% -53.14% -10.30% -4.44%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - -
Gross Margin
15.26% 28.72% 27.39% 25.06% 33.95% 40.71% 29.16% 28.99%
EBITDA Margin
-0.64% 27.09% 15.47% 11.34% 22.08% 32.36% 14.18% 13.38%
Operating Margin
4.60% 21.48% 9.27% 4.31% 17.25% 28.53% 9.45% 7.15%
EBIT Margin
-0.64% 18.61% 6.51% 1.83% 15.04% 27.05% 6.72% 4.37%
Profit (Net Income) Margin
7.19% 19.03% 6.13% 2.20% 11.47% 20.29% 4.41% 2.70%
Tax Burden Percent
-1,127.59% 102.26% 94.19% 120.16% 76.27% 75.02% 65.68% 61.62%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% -2.66% 24.16% -20.16% 23.73% 24.98% 34.32% 38.38%
Return on Invested Capital (ROIC)
1.16% 18.76% 4.50% 3.40% 11.46% 34.38% 12.63% 8.66%
ROIC Less NNEP Spread (ROIC-NNEP)
5.34% 8.83% 2.17% -3.36% 6.13% 69.78% 17.25% 12.48%
Return on Net Nonoperating Assets (RNNOA)
2.78% 3.07% 0.71% -1.37% 2.33% -3.36% -7.61% -5.84%
Return on Equity (ROE)
3.94% 21.83% 5.21% 2.03% 13.79% 31.02% 5.02% 2.82%
Cash Return on Invested Capital (CROIC)
0.00% -66.78% -1.30% 5.81% 9.50% 106.75% 23.49% 13.21%
Operating Return on Assets (OROA)
-0.17% 11.18% 2.83% 0.81% 8.58% 19.60% 3.64% 2.17%
Return on Assets (ROA)
1.92% 11.43% 2.67% 0.98% 6.54% 14.71% 2.39% 1.34%
Return on Common Equity (ROCE)
3.94% 21.83% 5.21% 2.03% 13.77% 30.96% 5.01% 2.82%
Return on Equity Simple (ROE_SIMPLE)
3.94% 14.63% 5.39% 2.05% 13.41% 29.77% 5.10% 2.87%
Net Operating Profit after Tax (NOPAT)
146 4,139 1,412 1,084 3,647 8,109 1,803 1,144
NOPAT Margin
3.22% 22.05% 7.03% 5.18% 13.16% 21.41% 6.20% 4.40%
Net Nonoperating Expense Percent (NNEP)
-4.18% 9.93% 2.34% 6.76% 5.34% -35.41% -4.63% -3.82%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - 4.79% 3.09%
Cost of Revenue to Revenue
84.74% 71.28% 72.61% 74.94% 66.05% 59.29% 70.84% 71.01%
SG&A Expenses to Revenue
4.71% 14.70% 15.00% 15.84% 13.77% 10.50% 13.85% 15.71%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
10.67% 7.24% 16.93% 20.74% 16.70% 12.18% 19.45% 20.32%
Earnings before Interest and Taxes (EBIT)
-29 3,494 1,308 382 4,168 10,246 1,952 1,136
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-29 5,086 3,107 2,371 6,119 12,258 4,121 3,475
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
0.00 1.00 1.06 1.12 1.72 0.00 1.05 0.91
Price to Tangible Book Value (P/TBV)
0.00 2.26 2.87 3.22 4.47 0.00 2.45 2.10
Price to Revenue (P/Rev)
0.00 1.30 1.21 1.20 1.46 0.00 0.91 0.85
Price to Earnings (P/E)
0.00 3.41 19.70 54.55 6.39 0.00 10.04 12.31
Dividend Yield
0.00% 4.18% 4.23% 4.10% 3.10% 2.72% 3.97% 6.03%
Earnings Yield
0.00% 29.36% 5.08% 1.83% 15.66% 0.00% 9.96% 8.12%
Enterprise Value to Invested Capital (EV/IC)
0.00 1.00 1.04 1.08 1.53 0.00 2.82 2.63
Enterprise Value to Revenue (EV/Rev)
0.00 1.68 1.68 1.63 1.77 0.00 1.31 1.31
Enterprise Value to EBITDA (EV/EBITDA)
0.00 6.19 10.84 14.40 8.01 0.00 9.24 9.76
Enterprise Value to EBIT (EV/EBIT)
0.00 9.01 25.74 89.36 11.76 0.00 19.50 29.86
Enterprise Value to NOPAT (EV/NOPAT)
0.00 7.60 23.84 31.50 13.44 0.00 21.11 29.66
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 15.33 9.19 10.27 12.61 0.00 13.30 12.09
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 18.42 16.22 0.00 11.35 19.45
Leverage & Solvency
- - - - - - - -
Debt to Equity
0.53 0.38 0.48 0.50 0.41 0.46 0.49 0.52
Long-Term Debt to Equity
0.45 0.32 0.41 0.49 0.32 0.35 0.40 0.41
Financial Leverage
0.52 0.35 0.33 0.41 0.38 -0.05 -0.44 -0.47
Leverage Ratio
2.05 1.91 1.95 2.08 2.11 2.11 2.10 2.11
Compound Leverage Factor
2.05 1.91 1.95 2.08 2.11 2.11 2.10 2.11
Debt to Total Capital
34.85% 27.77% 32.26% 33.15% 28.89% 31.44% 33.05% 34.04%
Short-Term Debt to Total Capital
5.73% 4.80% 4.38% 0.52% 6.32% 7.12% 6.18% 6.94%
Long-Term Debt to Total Capital
29.12% 22.97% 27.88% 32.64% 22.57% 24.32% 26.87% 27.10%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.12% 0.12% 0.09%
Common Equity to Total Capital
65.15% 72.23% 67.74% 66.73% 70.97% 68.44% 66.83% 65.86%
Debt to EBITDA
-153.14 1.85 3.51 4.69 1.57 0.97 3.02 3.63
Net Debt to EBITDA
-149.14 1.39 3.02 3.84 1.38 0.89 2.79 3.38
Long-Term Debt to EBITDA
-127.97 1.53 3.03 4.61 1.23 0.75 2.45 2.89
Debt to NOPAT
30.36 2.27 7.71 10.25 2.64 1.46 6.90 11.03
Net Debt to NOPAT
29.56 1.71 6.66 8.39 2.31 1.35 6.38 10.28
Long-Term Debt to NOPAT
25.37 1.88 6.67 10.09 2.06 1.13 5.61 8.78
Altman Z-Score
0.00 1.69 1.38 1.35 2.02 0.00 1.60 1.40
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.08% 0.18% 0.19% 0.18% 0.16%
Liquidity Ratios
- - - - - - - -
Current Ratio
2.07 1.40 1.17 1.35 1.11 1.14 1.17 1.15
Quick Ratio
0.38 0.68 0.46 0.60 0.47 0.50 0.52 0.52
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -14,735 -407 1,853 3,022 25,179 3,354 1,744
Operating Cash Flow to CapEx
-188.17% 0.00% 193.81% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - -
Asset Turnover
0.27 0.60 0.44 0.44 0.57 0.72 0.54 0.50
Accounts Receivable Turnover
9.30 9.80 5.84 5.83 6.16 6.55 5.01 4.82
Inventory Turnover
1.46 3.54 2.95 3.16 3.25 3.22 2.95 2.95
Fixed Asset Turnover
0.00 0.00 1.03 1.05 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 2.06 2.02 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
39.25 37.24 62.55 62.57 59.22 55.69 72.81 75.81
Days Inventory Outstanding (DIO)
250.66 103.16 123.80 115.37 112.25 113.43 123.85 123.54
Days Payable Outstanding (DPO)
0.00 0.00 176.97 180.47 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
289.91 140.40 9.39 -2.54 171.47 169.12 196.66 199.35
Capital & Investment Metrics
- - - - - - - -
Invested Capital
12,628 31,502 32,267 31,498 32,123 15,053 13,502 12,902
Invested Capital Turnover
0.36 0.85 0.64 0.66 0.87 1.61 2.04 1.97
Increase / (Decrease) in Invested Capital
0.00 18,874 1,819 -769 625 -17,070 -1,551 -600
Enterprise Value (EV)
0.00 31,465 33,669 34,135 49,020 0.00 38,059 33,920
Market Capitalization
0.00 24,388 24,271 25,040 40,596 0.00 26,516 22,123
Book Value per Share
$9.88 $39.09 $37.58 $39.04 $41.55 $47.95 $50.68 $49.39
Tangible Book Value per Share
$9.69 $17.26 $13.89 $13.58 $15.97 $20.71 $21.81 $21.34
Total Capital
12,744 33,816 33,759 33,514 33,325 37,721 37,640 37,057
Total Debt
4,441 9,391 10,890 11,111 9,626 11,858 12,439 12,615
Total Long-Term Debt
3,711 7,767 9,412 10,938 7,521 9,174 10,112 10,044
Net Debt
4,325 7,077 9,398 9,095 8,424 10,957 11,498 11,762
Capital Expenditures (CapEx)
651 0.00 1,891 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2,335 2,637 2,343 1,709 3,009 3,845 3,435 3,465
Debt-free Net Working Capital (DFNWC)
2,451 4,951 3,014 3,163 3,508 4,746 4,376 4,318
Net Working Capital (NWC)
1,721 3,327 1,536 2,990 1,403 2,062 2,049 1,747
Net Nonoperating Expense (NNE)
-181 566 180 625 468 422 521 444
Net Nonoperating Obligations (NNO)
4,325 7,077 9,398 9,095 8,424 -10,810 -11,699 -11,540
Total Depreciation and Amortization (D&A)
0.00 1,592 1,799 1,989 1,951 2,012 2,169 2,339
Debt-free, Cash-free Net Working Capital to Revenue
51.35% 14.05% 11.67% 8.17% 10.86% 10.15% 11.82% 13.34%
Debt-free Net Working Capital to Revenue
53.90% 26.37% 15.01% 15.13% 12.66% 12.53% 15.06% 16.63%
Net Working Capital to Revenue
37.85% 17.72% 7.65% 14.30% 5.06% 5.44% 7.05% 6.73%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $5.72 $3.40 $0.81 $5.53 $14.22 $2.53 $1.36
Adjusted Weighted Average Basic Shares Outstanding
0.00 624.90M 582.27M 569.66M 569.66M 538.48M 496.38M 494.20M
Adjusted Diluted Earnings per Share
$0.00 $5.72 $1.70 $0.81 $5.52 $14.18 $2.53 $1.36
Adjusted Weighted Average Diluted Shares Outstanding
0.00 624.90M 583.10M 569.69M 571.29M 540.01M 496.99M 494.37M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 608.54M 572.94M 569.26M 0.00 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
146 1,556 1,321 1,208 3,672 7,524 2,311 1,470
Normalized NOPAT Margin
3.22% 8.29% 6.58% 5.78% 13.25% 19.86% 7.95% 5.66%
Pre Tax Income Margin
-0.64% 18.61% 6.51% 1.83% 15.04% 27.05% 6.72% 4.37%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
100.92% 26.64% 82.95% 224.40% 32.87% 0.00% 0.00% 0.00%
Augmented Payout Ratio
100.92% 77.02% 239.61% 259.26% 65.43% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Nutrien

No quarterly metrics and ratios for Nutrien are available.


Frequently Asked Questions About Nutrien's Financials

When does Nutrien's fiscal year end?

According to the most recent income statement we have on file, Nutrien's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Nutrien's net income changed over the last 7 years?

Nutrien's net income appears to be on an upward trend, with a most recent value of $700 million in 2024, rising from $327 million in 2017. The previous period was $1.28 billion in 2023.

What is Nutrien's operating income?
Nutrien's total operating income in 2024 was $1.86 billion, based on the following breakdown:
  • Total Gross Profit: $7.53 billion
  • Total Operating Expenses: $5.28 billion
How has Nutrien revenue changed over the last 7 years?

Over the last 7 years, Nutrien's total revenue changed from $4.55 billion in 2017 to $25.97 billion in 2024, a change of 471.2%.

How much debt does Nutrien have?

Nutrien's total liabilities were at $27.40 billion at the end of 2024, a 0.5% decrease from 2023, and a 215.1% increase since 2017.

How much cash does Nutrien have?

In the past 7 years, Nutrien's cash and equivalents has ranged from $116 million in 2017 to $2.31 billion in 2018, and is currently $853 million as of their latest financial filing in 2024.

How has Nutrien's book value per share changed over the last 7 years?

Over the last 7 years, Nutrien's book value per share changed from 9.88 in 2017 to 49.39 in 2024, a change of 399.7%.

Remove Ads


This page (NYSE:NTR) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners